Alzheimer's Association Statement on Donanemab Phase 3 Topline Data Release

- Strongest Alzheimer's Phase 3 data release to date - - Association underscores urgent call for CMS to stop blocking access to FDA-approved treatments - - Full readout expected at Alzheimer's Association International Conference in July - CHICAGO, May 3, 2023 /PRNewswire/ -- On behalf of...